News

Filter

Current filters:

Pricing

176 to 185 of 1222 results

Colombia an attractive and fast-growing emerging pharma market

Colombia an attractive and fast-growing emerging pharma market

18-06-2014

The South American country Colombia has an attractive pharmaceutical market that should appeal to multinational…

ColombiaGenericsMarkets & MarketingPricingRegulationSouth America

UK’s NICE recommends Sucampo’s Amitiza for CIC

UK’s NICE recommends Sucampo’s Amitiza for CIC

18-06-2014

The UK health care watchdog the National Institute of Health and Care Excellence (NICE) has released…

AmitizaGastro-intestinalsPharmaceuticalPricingRegulationSucampoUK

Prime Therapeutics' 2013 overall net cost per Rx of $58.99 is industry-low for third consecutive year

Prime Therapeutics' 2013 overall net cost per Rx of $58.99 is industry-low for third consecutive year

17-06-2014

In 2013, US Pharmacy Benefit Manager (PBM) Prime Therapeutic's average net ingredient cost per prescription…

GenericsHealthcarePricingUSA

Added benefit of Invokana in type 2 diabetes is not proven, says IQWiG

Added benefit of Invokana in type 2 diabetes is not proven, says IQWiG

17-06-2014

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

DiabetesGermanyInvokanaJanssen-CilagJohnson & JohnsonPharmaceuticalPricingRegulation

UK NICE consults on draft guidance for Gilead’s hepatitis C drug Sovaldi

UK NICE consults on draft guidance for Gilead’s hepatitis C drug Sovaldi

16-06-2014

In draft recommendations published today, UK health care watchdog the National Institute for Health and…

Anti-viralsBiotechnologyGilead SciencesPricingRegulationSovaldiUK

New drug prices in India to be capped by NPPA

New drug prices in India to be capped by NPPA

16-06-2014

In order to keep a lid on the escalating cost of drugs, India's drug price regulator has decided to fix…

IndiaMachineryNatco PharmaPharmaceuticalPharmacyPoliticsPricingRetail priceSun Pharmaceuticals

UK’s NICE says “Yes” to Bristol-Myers’ Yervoy

UK’s NICE says “Yes” to Bristol-Myers’ Yervoy

13-06-2014

People in England with advanced skin cancer should be able to receive ipilimumab as a first treatment…

Bristol-Myers SquibbOncologyPharmaceuticalPricingRegulationUKYervoy

Large increase seen in insulin use, out-of-pocket costs for type 2 diabetes

11-06-2014

Largely attributable to the widespread adoption of insulin analogs, use of insulin among patients with…

DiabetesHealthcarePharmaceuticalPricingUSA

176 to 185 of 1222 results

COMPANY SPOTLIGHT

Menarini

Back to top